The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy.

MLA

Yarlas, Aaron, et al. “The Impact of Inotersen on Neuropathy Impairment Score in Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy.” BMC Neurology, vol. 23, no. 1, Mar. 2023, pp. 1–14. EBSCOhost, https://doi.org/10.1186/s12883-023-03116-7.

APA

Yarlas, A., Lovley, A., Brown, D., Vera-Llonch, M., Khella, S., & Karam, C. (2023). The impact of inotersen on Neuropathy Impairment Score in patients with hereditary transthyretin amyloidosis with polyneuropathy. BMC Neurology, 23(1), 1–14. https://doi.org/10.1186/s12883-023-03116-7

Chicago

Yarlas, Aaron, Andrew Lovley, Duncan Brown, Montserrat Vera-Llonch, Sami Khella, and Chafic Karam. 2023. “The Impact of Inotersen on Neuropathy Impairment Score in Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy.” BMC Neurology 23 (1): 1–14. doi:10.1186/s12883-023-03116-7.